LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia

Although great advances have been made in understanding the pathobiology of mixed lineage leukemia-rearranged (MLL-r) leukemias, therapies for this leukemia have remained limited, and clinical outcomes remain bleak. In order to identify novel targets for immunotherapy treatments, we compiled a linea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gracia-Maldonado, Gabriel, Clark, Jason, Burwinkel, Matthew, Greenslade, Brenay, Wunderlich, Mark, Salomonis, Nathan, Leone, Dario, Gatti, Evelina, Pierre, Philippe, Kumar, Ashish R., Lee, Lynn H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968879/
https://www.ncbi.nlm.nih.gov/pubmed/33910331
http://dx.doi.org/10.3324/haematol.2020.257451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968879/
https://www.ncbi.nlm.nih.gov/pubmed/33910331
http://dx.doi.org/10.3324/haematol.2020.257451

Ejemplares similares